Home › Funds › Soleus Capital Management, L.P. › GMED

Soleus Capital Management, L.P. position in GMED

GLOBUS MED INC · Health Care

Soleus Capital Management, L.P. reported holding 468,922 shares of GMED (GLOBUS MED INC) in its Q2 2026 13F filing — a position valued at US$37.0M, representing 1.28% of its reported portfolio and ranking #21 among its reported holdings. Soleus Capital Management, L.P. has disclosed GMED holdings in 5 of the last 9 reported quarters, going back to Q2 2024.

Latest position (Q2 2026)468.92K sh
Reported value held$37.05M
Portfolio Weight1.28%
First reportedQ2 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Soleus Capital Management, L.P.'s GMED position evolved

Soleus Capital Management, L.P. first disclosed a stake in GMED in Q2 2024 at 86,000 shares (US$5.9M). The position peaked in Q4 2025 at 887,000 shares, worth US$77.4M. Across 5 filings, Soleus Capital Management, L.P. increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 468,922 shares valued at US$37.0M — a reduction of -260,545 shares quarter over quarter.. Notable position changes include a 404% increase in Q4 2025 (shares fell 1% over the following quarter), a 36% trim in Q2 2026 (shares fell 5% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 86.00K $5.89M New
Q3 2025 176.00K $10.08M New
Q4 2025 887.00K $77.44M Add
Q1 2026 729.47K $62.85M Reduce
Q2 2026 468.92K $37.05M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GMED and 13F data

GMED (GLOBUS MED INC) is a Health Care company. 39 other funds we track also report a position in GMED — the largest reported positions include KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC (US$338.1M), Sculptor Capital LP (US$237.0M), Boston Trust Walden Corp (US$124.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GMED

All GMED fund holders →

FAQ

How long has Soleus Capital Management, L.P. held GMED?

Soleus Capital Management, L.P. has disclosed GMED holdings in 5 of the last 9 reported quarters, going back to Q2 2024.

What is Soleus Capital Management, L.P.'s current position in GMED?

As of Q2 2026, Soleus Capital Management, L.P. holds 468.92K shares of GMED (GLOBUS MED INC), valued at $37.05M, representing 1.28% of its reported portfolio and ranking #21.

Has Soleus Capital Management, L.P. been buying or selling GMED?

In the latest 13F filing (Q2 2026), Soleus Capital Management, L.P. reduced its position in GMED. The position peaked in Q4 2025 at 887.00K shares.

Which other funds hold GMED?

Other major institutional holders of GMED include KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC, Sculptor Capital LP, Boston Trust Walden Corp, among 39 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.